| Acceptance rate | 46% |
|---|---|
| Time to first decision | 20 days* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2020 , Vol 58 , Num 4
Molecular Drug Design and Docking Study of Novel N- substituted Celecoxib Derivatives as Selective Cyclooxygenase-2 Inhibitors
1 College of Education for Women, University of Anbar, Department of Chemistry, Ramadi, Iraq2 College of Pharmacy, Mustansiriyah University, Department of Pharmaceutical Chemistry, Baghdad, Iraq
DOI : 10.23893/1307-2080.APS.05823 Keywords :